Transfusion technology has improved considerably. The risks of transfusion are not zero, but they are as low now as they ever have been. At the same time, transfusion committees see that blood products are properly used. In most situations today, transfusion therapy means blood component therapy – red blood cells for anemia, platelets for thrombocytopenia (low platelets) and plasma for factor...
To access content, please login or purchase a subscription.
